Similar Posts
India sees minimal impact from US trade policies, but risks persist: UBI Report – Equitypandit
March 21, 2025March 21, 2025 India’s economy may avoid major fallout from US trade tensions due to its trade balance. Still, the final impact depends on upcoming trade negotiations, according to a Union Bank of India report. While the economy remains resilient, currency fluctuations and liquidity conditions are being…
Friday File: Cold Quarter… and a Bunch of Little Buys
With the S&P 500 down about 3% this week, and the Nasdaq down even more, I’m starting to see some more appealing prices flash through for some of the companies I know well and really like, so I’ve done some buying throughout the portfolio, all in pretty small bites — these purchases in total add…
India’s Business Activity Hits 3-Month High in Nov Amid Rising Costs – Equitypandit
November 22, 2024November 22, 2024 India’s business activity saw its fastest growth in three months in November, driven by a strong services sector and record job creation, despite a surge in output inflation to a near 12-year high. India’s business activity grew at its fastest pace in three months…
Dividend Fortunes: 2 Canadian Stocks Leading the Way to Retirement
Image source: Getty Images Dividend investing is an excellent way to help anyone achieve their retirement goal of living the lifestyle they want. The stock market offers plenty of opportunities for Canadian investors to build portfolios of income-generating assets with far better returns than with high-interest savings accounts of government-issued bonds. Unlike real estate, stock market…
OceanFirst Financial Corp. (OCFC) Q3 2024 Earnings Call Transcript
OceanFirst Financial Corp. (NASDAQ:OCFC) Q3 2024 Earnings Conference Call October 18, 2024 11:00 AM ET Company Participants Alfred Goon – Senior Vice President, Corporate Development and Investor RelationsChristopher Maher – Chairman and Chief Executive OfficerJoseph Lebel – President and Chief Operating OfficerPatrick Barrett – Executive Vice President and Chief Financial Officer Conference Call Participants Frank…
Lupin Signs US Licensing Deal for Cancer Biosimilar; Shares End Flat
December 4, 2025December 4, 2025 Shares of Lupin Ltd ended flat on 4th December, even though the firm said it has signed an exclusive licensing agreement with US-based Valorum Biologics for its biosimilar Armlupeg (pegfilgrastim-unne). Under the agreement, Valorum will handle the commercialisation and distribution…


